{"metadata":{"topics":["Accountability","Administrative law","Applied ethics","Arithmetic","Artificial objects","Australian dollar","Average","Banking","Biochemistry","Biology","Bionovo","Biotechnology","Business","Business economics","Business law","Business organizations","California","Cancer","Capital (economics)","Capital market","Capital requirement","Cash","Causes of death","Chairman","Change","Chemistry","Chicago","Chief executive officer","Chief financial officer","Civil law (common law)","Civil law (legal system)","Clinical medicine","Clinical research","Clinical trial","Cognition","Cognitive science","Common law","Common stock","Companies","Companies of the United States","Company","Competition","Contract law","Corporate finance","Corporate governance","Corporate law","Corporate personhood","Corporations","Cost","Covenant (law)","Culture","Damages","Diseases and disorders","Drug development","Drug discovery","Drugs","Economic law","Economic sectors","Economics","Economies","Economy","Economy of the United States","Efficacy","Email","Emergence","Emeryville, California","Energy","Environmental law","Environmental social science","Equity securities","Ethical principles","Ethically disputed business practices","Ethics","Executive branch of the United States government","Finance","Financial economics","Financial law","Financial markets","Financial regulation","Financial risk","Financial services","Financial services organizations","Form 8-K","Form S-1","Forward-looking statement","Funding","Governance","Government","Government agencies","Government information","Government of the United States","Government-related organizations","Health","Health care","Health economics","Health policy","Health research","Health sciences","Healthcare industry","Healthcare quality","Human activities","Hypertext Transfer Protocol","Illinois","Industries","Industry","Information","Institutional investor","Institutional investors","Intellectual property","Intellectual property law","Intellectual works","Investment","Investment companies","Investor","Jurisdiction","Justice","Law","Law and economics","Legal concepts","Legal documents","Legal fictions","Life sciences","Life sciences industry","Liquidated damages","Lytham St Annes","Management","Market (economics)","Marketing","Mechanism of action","Medical research","Medical specialties","Medical treatments","Medication","Medicinal chemistry","Medicine","Menopause","Microeconomics","Money","Monopoly (economics)","Morality","NASDAQ","Natural resources law","Natural sciences","Nature","Neoplasms","Official documents","Oncology","Organization","Patent","Pharmaceutical industry","Pharmaceutical sciences","Pharmaceutics","Pharmacology","Pharmacy","Physical sciences","Physician","Pipeline transport","Political economy","Political science","Politics","Politics of the United States","Price","Private law","Products of chemical industry","Property","Property law","Public administration","Public health","Public law","Public policy","Public sphere","Regulation","Reimbursement","Research","Revenue","Right of first refusal","Rights","Risk","Robert Blum","Science","Science and technology","Securities (finance)","Securities Act of 1933","Securities and exchange commissions","Securities regulation in the United States","Security","Security (finance)","Service companies","Service industries","Services (economics)","Share (finance)","Share price","Social institutions","Social issues","Sociological theories","Statutory law","Stock","Stock market","Symbol","Technology","Therapy","Truth","U.S. Securities and Exchange Commission","Uncertainty","United States","United States administrative law","United States business law","United States dollar","United States economic policy","United States federal policy","United States law","United States regulations","United States securities law","Vice president","Virtue","Women's health","Working capital","World economy"],"person_names":["isaac cohen","joe diaz","o.m.d.","robert blum","tom chesterman"],"vars":{},"organization_names":["about bionovo, inc.","aspire capital","aspire capital fund llc","bionovo","inc.","lytham partners tel","nasdaq","nasdaq capital market"],"agreement_id":"28f2e1d5e622057622047f56c46a7a57fd8d837d72e4409243062f39650d7ed3","terms":["***This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction***","**About Aspire Capital Fund**","**About Bionovo, Inc.**","**Bionovo Announces A $[[USD Value 1: Number]] Million At-The-Market**","**Firm Commitment Financing Agreement**","**Forward Looking Statements**","**[[Email 1]]**","**[[Email 2]]**","**http://w****","**http://www.sec.gov**"]}}